Steroid therapy and the risk of osteonecrosis in SARS patients: a dose-response meta-analysis

Osteoporosis International

Volumn 28, Issue 3, 2017, Pages 1027-1034

  Zhao, R ^a,b   Wang, H ^c   Wang, X ^b   Feng, F ^b  

^a YANGZHOU UNIVERSITY   (China)

^b ZHEJIANG NORMAL UNIVERSITY   (China)

^c Department of Ophthalmology   (China)

Author keywords

Dose response; Osteonecrosis; SARS; Sex difference; Steroid therapy

Indexed keywords

METHYLPREDNISOLONE; PREDNISOLONE; GLUCOCORTICOID;

ADVERSE OUTCOME; ARTICLE; BONE NECROSIS; DOSE RESPONSE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SEVERE ACUTE RESPIRATORY SYNDROME; SEX DIFFERENCE; STEROID THERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION; CHEMICALLY INDUCED; DRUG ADMINISTRATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX FACTOR;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GLUCOCORTICOIDS; HUMANS; OSTEONECROSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERE ACUTE RESPIRATORY SYNDROME; SEX FACTORS;

EID: 84995390472     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-016-3824-z     Document Type: Article

References (35)

1. Lamberts SW, Bruining HA, de Jong FH (1997) Corticosteroid therapy in severe illness. N Engl J Med 337:1285–1292
2. Boland EW, Headley NE (1950) Management of rheumatoid arthritis with smaller (maintenance) doses of cortisone acetate. J Am Med Assoc 144:365–372
3. Freyberg RH, Traeger CH, Patterson M, Squires W, Adams CH (1951) Problems of prolonged cortisone treatment for rheumatoid arthritis; further investigations. J Am Med Assoc 147:1538–1543
4. Powell C, Chang C, Naguwa SM, Cheema G, Gershwin ME (2010) Steroid induced osteonecrosis: an analysis of steroid dosing risk. Autoimmun Rev 9:721–743
5. Weinstein RS (2012) Glucocorticoid-induced osteonecrosis. Endocrine 41:183–190
6. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94–124
7. Chan-Yeung M, Ooi GC, Hui DS, Ho PL, Tsang KW (2003) Severe acute respiratory syndrome. The International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 7:1117–1130
8. Ho JC, Ooi GC, Mok TY et al (2003) High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome. Am J Respir Crit Care Med 168:1449–1456
9. Guo KJ, Zhao FC, Guo Y, Li FL, Zhu L, Zheng W (2014) The influence of age, gender and treatment with steroids on the incidence of osteonecrosis of the femoral head during the management of severe acute respiratory syndrome: a retrospective study. The Bone Joint J 96-B:259–262
10. Wu LH, Gao C, Wang GZ, Yang L, Hou XM, Ge H, Xia CQ, Qi M (2006) Clinical study on the relate marker of blood coagulation in the patients with avascular necrosis of the femoral head after treatment of severe acute respiratory syndrome with methylprednisolone. Chinese J Nautical Med Hyperbaric Med 13:39–41
11. Dong WQ, Bai B, Lin YP, Zeng QS (2007) Case control study of avascular necrosis of femoral head during SARS patients’ convalescence. Chinese J Postgraduates of Med 30:1–3
12. Gao HS, Wang SX, Gao X, Cao X, Hui WL, Li YM, Yang Z, Su B (2005) Nested case-control study of avascular necrosis of femoral head during SARS patients’convalescence. Acta Academiae Medicinae CPAPF 14:11–13
13. Griffith JF, Antonio GE, Kumta SM et al (2005) Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids. Radiology 235:168–175
14. Han YK, Zhou XZ, Zeng Z et al (2005) Osteonecrosis in post-SARS patients: a clinical study. Chinese J Nosocomiol 15:481–484
15. Liu BL, Li ZR, Sun W, Zhao FC (2009) The relationship of the range and location of osteonecrosis of the femoral head with the dose of steroid in SARS patients. Chin J Orthop 29:554–557
16. Lv H, de Vlas SJ, Liu W, Wang TB, Cao ZY, Li CP, Cao WC, Richardus JH (2009) Avascular osteonecrosis after treatment of SARS: a 3-year longitudinal study. Tropical Med Int Health: TM & IH 14(Suppl 1):79–84
17. Wang HY (2011) The investigation of the SARS patients with ANFH in Beijing Ditan Hospital. Taishan Medical Institute, Taian, pp 1–52
18. Wang ZQ, Liu TS, Wang JG (2006) The clinical research of the SARS patients diagnosed with femur head necrosis. Tianjin Med J 34:50–51
19. Xu J, Yu XZ (2004) A study on correlativity between glucocorticoids and femoral head necrosis in patients with severe acute respiratory syndrome. Chinese J Emerg Med 13:697–699
20. Zhang NF, Li ZR, Wei HY, Liu ZH, Hernigou P (2008) Steroid-induced osteonecrosis: the number of lesions is related to the dosage. J Bone Joint Surg Brit Vol 90:1239–1243
21. Cheng XG, Qu H, Liu W, Liu X, Cheng KB, Zhao T, Li XS, Liang W, Guo J (2005) The prevalence of osteonecrosis in severe acute respiratory syndrome patients: an MRI screening study. Chin J Radiol 39:791–797
22. Cheng XG, Qu H, Liu W, Sun J, Cheng KB, Feng SC, Li XS (2004) MRI screening on bone ischemia of hip and knee in recovered SARS patients. Chinese J Radiol 38:230–235
23. Chen WH, Zhang Q, Liu DB, Zhang HM, Zhang L, Gu LJ, Sun G, Zhao TJ, Zhou W (2004) Analysis of attacking characteristics and clinical significant about osteonecrosis of the femoral head secondary to SARS. China J Orthopaedics Traumatol 17:388–390
24. Felson DT, Anderson JJ (1987) Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet 1:902–906
25. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269 W264
26. Wang Z, Liu T, Wang J (2007) The clinical research of the SARS patients diagnosed with Femur Head Necrosis. Orthopaedic new technology seminar for the police force, Tianjing, pp 190–192
27. Higgins J, Green S (2008) Cochrane Reviewers’ handbook 5.0.1 (updated September 2008). The Cochrane library. Wiley, Chichester
28. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
29. Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135:1301–1309
30. Desquilbet L, Mariotti F (2010) Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29:1037–1057
31. Nakamura J, Harada Y, Oinuma K, Iida S, Kishida S, Takahashi K (2010) Spontaneous repair of asymptomatic osteonecrosis associated with corticosteroid therapy in systemic lupus erythematosus: 10-year minimum follow-up with MRI. Lupus 19:1307–1314
32. Shibatani M, Fujioka M, Arai Y, Takahashi K, Ueshima K, Okamoto M, Yoshimura N, Hirota Y, Fukushima W, Kubo T (2008) Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head. Acta Orthop 79:631–636
33. Klipper AR, Stevens MB, Zizic TM, Hungerford DS (1976) Ischemic necrosis of bone in systemic lupus erythematosus. Medicine 55:251–257
34. Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB (1985) Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med 79:596–604
35. Saito M, Ueshima K, Fujioka M, Ishida M, Goto T, Arai Y, Ikoma K, Fujiwara H, Fukushima W, Kubo T (2014) Corticosteroid administration within 2 weeks after renal transplantation affects the incidence of femoral head osteonecrosis. Acta Orthop 85:266–270